Global Registration and Supply Shortages (Taipei)

» Download the Agenda

Documents

safety_and_immunogenicity_of_a_combined_tetanus_diphtheria_recombinant_acellular_pertussis_vaccine_tdap_in_healthy_thai_adults.pdf

challenges_for_registration_of_vaccines.pdf

international_procurement_and_supply_schemes_part_1.pdf

international_procurement_and_supply_schemes_part_2.pdf

supply_and_shortages.pdf

collaborations.pdf

taipei_workshop_agenda_01.03.17.pdf

dcvmn_taipei_paologolfetto_170306_vhandout.pdf

bio_farma_presentation_in_taipei_march_2017_.pdf

immunogenicity_and_safety_of_an_e._coli-produced_bivalent_human_papillomavirus_type_16_and_18_vaccine_a_randomized_controlled_phase_2_clinical_trial.pdf

challenges_for_registration_of_vaccines-2.pdf

global_overview_of_registration.pdf

sipv-taipei.pdf

ge_healthcare_dcvmn_qbd_in_process_development_incl_exercise_29256324aa_10mar2017.pdf

ge_healthcare_dcvmn_vaccine_downstream_processin_an_overview_29256326aa_10mar2017.pdf

ge_healthcare_dcvmn_vaccine_upstream_processing_an_overview_10mar2017.pdf

ge_healthcare_dcvmn_process_economy_for_vaccines_29256324aa_10mar2017.pdf

ge_healthcare_dcvmn_introduction_to_pd_for_vaccine_production_29256323aa_10mar2017.pdf

test_1_correct_answers.pdf

siipl_mcv.pdf

siipl_bcg.pdf

vvm-en-2017_0305taipei.pdf

bionet_ap_dcvmn_mar2017_publish.pdf

---

---